Clinical Trials at Wake Forest University at Clemmons
As of August 2026, 14 paid clinical trials are recruiting at Wake Forest University at Clemmons in Clemmons, North Carolina. Active studies at this site cover conditions such as Lung Non-Small Cell Carcinoma, Acral Lentiginous Melanoma and Anaplastic Large Cell Lymphoma, ALK-Negative. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials at Wake Forest University at Clemmons
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Common conditions studied in Clemmons
- Lung Non-Small Cell Carcinoma (2 active studies)
- Acral Lentiginous Melanoma (1 active study)
- Anaplastic Large Cell Lymphoma, ALK-Negative (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Clemmons
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Wake Forest University Health Sciences
- Canadian Cancer Trials Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Clemmons?
There are approximately 16 recruiting clinical trials in Clemmons, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Clemmons pay participants?
Most recruiting trials in Clemmons compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Clemmons?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Clemmons?
The most common conditions under active study in Clemmons include Lung Non-Small Cell Carcinoma (2), Acral Lentiginous Melanoma (1), Anaplastic Large Cell Lymphoma, ALK-Negative (1), Anatomic Stage II Breast Cancer AJCC v8 (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Clemmons?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Clemmons on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Clemmons?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Clemmons?
Recruiting research sites in Clemmons include Wake Forest University at Clemmons, Novant Health Colon and Rectal Clinic, Forsyth County, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Clemmons right now?
The largest active categories in Clemmons are Cancer & tumors (15), Mental health & behavior (1), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.